Innate Immunotherapeutics Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Innate Immunotherapeutics Ltd with three other
companies in this sector in Australia:
sales of 2.01 million Australian Dollars [US$1.60 million]
(1.80 million Australian Dollars [US$1.43 million]
of which 100%
was Dermaportation & ET Technologies), and
(1.66 million Australian Dollars [US$1.32 million]
Innate Immunotherapeutics Ltd reported sales of A$1.83 million (US$1.46 million)
March of 2017.
decrease of 20.2%
versus 2016, when the company's sales were A$2.29 million.